VV-14305

· Kriya Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VV-14305, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VV-14305 for the Treatment of Thyroid Eye Disease [Phase 1, Phase 2]